Genomma Lab Internacional, S.A.B. de C.V.'s latest marketcap:
As of 07/05/2025, Genomma Lab Internacional, S.A.B. de C.V.'s market capitalization has reached $1.08 B. According to our data, Genomma Lab Internacional, S.A.B. de C.V. is the 9194th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 1.08 B |
| Revenue (ttm) | 920.59 M |
| Net Income (ttm) | 108.51 M |
| Shares Out | 0 |
| EPS (ttm) | 0.11 |
| Forward PE | 7.96 |
| Ex-Dividend Date | n/a |
| Earnings Date | 07/23/2025 |
Genomma Lab Internacional, S.A.B. de C.V.'s yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | $1.08 B | -3.55% | 9194 |
| 12/31/2024 | $1.12 B | 43.29% | 45482 |
| 12/29/2023 | $778.5 M | -9.87% | 43849 |
| 12/30/2022 | $863.79 M | -18.07% | 42182 |
| 12/31/2021 | $1.05 B | 10.06% | 40309 |
| 12/31/2020 | $957.93 M | -4.56% | 37274 |
| 12/31/2019 | $1 B | 79.2% | 34731 |
| 12/31/2018 | $560.11 M | -43.66% | 33460 |
| 12/29/2017 | $994.16 M | -2.54% | 32048 |
| 12/30/2016 | $1.02 B | 24.09% | 30119 |
Company Profile
About Genomma Lab Internacional, S.A.B. de C.V.
Genomma Lab Internacional, S.A.B. de C.V. is a leading pharmaceutical and personal care company headquartered in Mexico City, Mexico. Founded in 1996, the company operates both domestically and internationally, offering a diverse portfolio of branded healthcare and wellness products.
Product Portfolio
The company specializes in developing, selling, and marketing a wide range of products across multiple categories, including:
- Anti-acne treatments & self-diagnosis solutions
- Antibacterial & antifungal products
- Skincare (scar improvement, anti-wrinkle creams)
- Haircare (shampoos, dandruff treatments, anti-hair loss solutions)
- Personal hygiene (soaps, razors)
- Pain relief (muscle ointments, osteoarthritis treatments)
- Digestive health (antacids, anti-ulcer, anti-colitic medications)
- Cold & flu remedies
- Hemorrhoid & varicose vein treatments
- Ophthalmic medications
- Infant nutrition products
With a strong presence in Mexico and expanding global reach, Genomma Lab Internacional continues to deliver high-quality healthcare solutions to consumers worldwide.
Frequently Asked Questions
-
What is Genomma Lab Internacional, S.A.B. de C.V.'s (OTC-GNMLF) current market cap?As of 07/05/2025, Genomma Lab Internacional, S.A.B. de C.V. (including the parent company, if applicable) has an estimated market capitalization of $1.08 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Genomma Lab Internacional, S.A.B. de C.V. (OTC-GNMLF) rank globally by market cap?Genomma Lab Internacional, S.A.B. de C.V. global market capitalization ranking is approximately 9194 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.